Metformin’s effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway

ABSTRACT:

SUBMITTER: Chen H 

PROVIDER: S-EPMC11685231 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature